Discovery of New Cancer in the 1-year Follow-up After Ischemic Stroke in Patients at Risk: The INVISIBLE-1 Study

Clinical trial NCT06100718 · RECRUITING

Trial details

NCT number: NCT06100718
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: RECRUITING
Study type: OBSERVATIONAL

Cancer-related Stroke Paraneoplastic Coagulopathy Occult Cancer Ischemic Stroke Embolic Stroke of Undetermined Source D-dimer

Start date: 2022-01-01
Primary completion: 2025-12-31
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.